ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000254.1|Oxytetracycline_1 # 173 # 625 # 1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.755	BGC0000254.1|Oxytetracycline_1 	173	625	+	Loose	210	31.5722	Escherichia coli AcrAB-TolC with MarR mutations conferring resistance to ciprofloxacin and tetracycline	29.85	3003378	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACCGCCGAGGTCTTCGCGGTCAACGGCCGCCTGCTCCGCGAAGGCGACAGCCTCACCGCCCACGCGGGGCTGACCTCGGCGCGCTGGCAGGTGGCCGGACTGCTGCTGAGCGGCCCCTCGACGGTCGCCCGCCTGGCCCGCGAGCGGGGGCTGCGGCGGCAGGCGGTCCAGCAGACCGTCGAGCGGCTGAAGGCCGAGGGCGTCGTCACGACCCGGCCCAACCCGCAGGACCAGCGCAGCCCCCTGGTCGAGCTCACCGCACGCGGCCGGCAGGCGCTGGACGACCTGCGTCCCCTGGAACGGCGGTGGCTGGAGTATCTGGCCGAGGACATTCCGGTCGAGGACATGCGCGTGGCGATCGCGGTGCTGAGCCGCCTGCGGGAGAAGCTGGACGCCCGTCCGGCGACGGAGTTCGGGACCGGGGCCGGGTCCGGGCGGCAGTCCGCCTGA	VTAEVFAVNGRLLREGDSLTAHAGLTSARWQVAGLLLSGPSTVARLARERGLRRQAVQQTVERLKAEGVVTTRPNPQDQRSPLVELTARGRQALDDLRPLERRWLEYLAEDIPVEDMRVAIAVLSRLREKLDARPATEFGTGAGSGRQSA	MKSTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVELKKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGGAAICEQCHQLVGQDLHQELTKNLTADEVATLEYLLKKVLP	104.17	gnl|BL_ORD_ID|1984|hsp_num:0	431			111	312	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000254.1|Oxytetracycline_4 # 3388 # 3675 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=CCCCG;rbs_spacer=15bp;gc_cont=0.708	BGC0000254.1|Oxytetracycline_4 	3388	3675	+	Loose	550	28.1054	APH(2'')-IIa	29.31	3002635	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2'')	ATGACCCTGCTCACCCTCTCCGACCTGCTCACCCTGCTGCGCGAGTGCGCGGGCGAGGAGGAATCCATCGACCTGGGAGGGGACGTCGAGGACGTCGCCTTCGACGCCCTCGGCTACGACTCGCTGGCGCTGCTGAACACCGTGGGACGCATCGAGCGCGACTACGGGGTCCAGCTCGGGGACGACGCGGTGGAGAAGGCGACCACGCCGCGCGCCCTGATCGAGATGACCAACGCGTCGCTCACCGGCGCGTCCCCGTCCGCGGGTGGCGCCGCGCGGGACAAGTGA	MTLLTLSDLLTLLRECAGEEESIDLGGDVEDVAFDALGYDSLALLNTVGRIERDYGVQLGDDAVEKATTPRALIEMTNASLTGASPSAGGAARDK	MVNLDAEIYEHLNKQIKINELRYLSSGDDSDTFLCNEQYVVKVPKRDSVRISQKRELELYRFLENCKLSYQIPAVVYQSDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKELHSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTDEMLEHIETIYENILSNAVLFKYTPCLVHNDFSANNMIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGRKVLKYYQHKAPEVAERKAELNDVYWSIDQIIYGYERKDREMLIKDVSELLQTQAEMFIF	31.77	gnl|BL_ORD_ID|1476|hsp_num:0	1615			234	408	plazomicin
BGC0000254.1|Oxytetracycline_5 # 3653 # 5524 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=CCGGCG;rbs_spacer=15bp;gc_cont=0.717	BGC0000254.1|Oxytetracycline_5 	3653	5524	+	Loose	700	27.335	MOX-7	26.03	3002189	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	MOX beta-lactamase	GTGGCGCCGCGCGGGACAAGTGAGGACCGGCCGATGTGCGGAATCGCCGGCTGGATCGATTTCGAACGCAATCTGGCGCAGGAGCGGGCGACGGCCTGGGCCATGACGGACACCATGGCCTGCCGGGGCCCGGACGACGCGGGCCTGTGGACCGGTGGCCACGCGGCGCTCGGCCACCGCAGGCTGGCCGTCATCGACCCGGCGCACGGGCGGCAGCCGATGCACAGCACGCTGCCGGACGGCACGAGCCACGTCATCACGTTCAGCGGGGAGATCTACAACTTCCGTGAACTGCGGGTCGAGCTGGAGTCCCAGGGGCACCGCTTCCGTACCCACTGCGACACGGAGGTGGTGCTGCACGGCTACACCCGGTGGGGCCGGGAGCTGGTGGACCGGCTCAACGGCATGTACGCGTTCGCCGTGTGGGACGAGGCCCGGCAGGAACTGCTGCTGGTCCGCGACCGGATGGGGGTCAAGCCGCTCTACTACCACCCCACCGCCACCGGTGTGCTGTTCGGCTCCGAGCCGAAGGCCGTGCTCGCGCACCCCTCGCTGCGGCGGCGGGTGACGGCCGAGGGCCTGTGCGAGGTGCTGGACATGGTCAAGACCCCCGGCCGGACCGTCTTCTCCGGTATGCGCGAGGTGCTGCCGGGCGAGATGGTCACCGTCGGGCGCTCCGGTGTGGCCCGCAGGCGGTACTGGACGCTCCAGGCGCGGGAGCACACCGACGATCTGGAGACCACCATCGCCACGGTGCGCGGCCTGCTGACGGACAGGGTGCGCCGGCAGCTGGTCTCCGATGTGCCGCTGTGCACCCTGCTCTCCGGCGGGCTGGACTCGTCGGCGGTGACGGCGCTGGCGGCGCGGGCGGGCGACGGGCCGGTCCGTACGTTCTCGGTGGACTTCTCCGGCGCGGGCACCCGGTTCCAGCCGGACGCCGTACGGGGCAACACGGACGCGCCGTACGTCCAGGAGATGGTGCGGCACGTGGCGGCGGACCATACGGAAGTCGTGCTGGACAGCGCCGATCTCGCGGCACCCGAGGTGCGTGCCGCCGTCCTGGGGGCCACCGACCTGCCCCCGGCGTTCTGGGGCGACATGTGGCCCTCGCTGTACCTGTTCTTCCGGCAGGTGCGGCAGCACTGCACGGTGGCCCTGTCGGGCGAGGCGGCGGACGAACTCTTCGGCGGTTACCGGTGGTTCCACCGGACGGCGGCCATCGACGCCGGTACGTTCCCCTGGCTGACCGCCGGCTCGGCCCGGTACTTCGGCGGCCGGGGCCTGTTCGACCGCAAGCTGCTGGACAAGCTCGACCTGCCGGGCTACCAGCGCGACCGGTACGCCGAGGCCCGTAAGGAAGTCCCCGTCCTGCCCGGCGAGGACGCGCGGGAGGCGGAGCTGCGCCGGGTGACCTACCTCAACCTCACCCGCTTCGTGCAGACCCTGCTGGACCGCAAGGACCGGATGAGCATGGCGACCGGCCTGGAGGTGCGGGTGCCGTTCTGCGACCACCGGCTGGTCGACTACGTCTTCAACGTGCCGTGGGCCATGAAGTCCTTCGACGGCAGGGAGAAGAGCCTGCTGCGGGCCGCGGTGCGCGACCTGCTGCCGGAGTCGGTGGTCACCCGGGTCAAGACGCCCTACCCCGCCACACAGGACCCGGTCTACGAGCGGCTGTTGCGCGACGAACTGGCCGCGCTGCTGGCCGACAGCCAGGCGCCGGTCCGCGAACTGCTCGACCTGGGTCGGGCGCGCGACCTGCTGCGGCGGCCGGTCGGCGCCGTCAGCCAACCGTACGACCGCGGCAGTCTGGAGCTGGTCCTGTGGATGAACACCTGGCTGGCGGAGTACGGCGTCAGCCTGGAGCTATGA	MAPRGTSEDRPMCGIAGWIDFERNLAQERATAWAMTDTMACRGPDDAGLWTGGHAALGHRRLAVIDPAHGRQPMHSTLPDGTSHVITFSGEIYNFRELRVELESQGHRFRTHCDTEVVLHGYTRWGRELVDRLNGMYAFAVWDEARQELLLVRDRMGVKPLYYHPTATGVLFGSEPKAVLAHPSLRRRVTAEGLCEVLDMVKTPGRTVFSGMREVLPGEMVTVGRSGVARRRYWTLQAREHTDDLETTIATVRGLLTDRVRRQLVSDVPLCTLLSGGLDSSAVTALAARAGDGPVRTFSVDFSGAGTRFQPDAVRGNTDAPYVQEMVRHVAADHTEVVLDSADLAAPEVRAAVLGATDLPPAFWGDMWPSLYLFFRQVRQHCTVALSGEAADELFGGYRWFHRTAAIDAGTFPWLTAGSARYFGGRGLFDRKLLDKLDLPGYQRDRYAEARKEVPVLPGEDAREAELRRVTYLNLTRFVQTLLDRKDRMSMATGLEVRVPFCDHRLVDYVFNVPWAMKSFDGREKSLLRAAVRDLLPESVVTRVKTPYPATQDPVYERLLRDELAALLADSQAPVRELLDLGRARDLLRRPVGAVSQPYDRGSLELVLWMNTWLAEYGVSLEL	MQQRQSILWGALATLMWAGLVHAGDKAATDPLRPVVDASIRPLLKEHRIPGMAVAVLKDGKAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGSFELDDKASLFAPWLKGSVFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYANPSIGLFGYLAASSMKQPFDRLMEQTMLPGLGLYHTYLTVPEQAMGHYAYGYSKEDKPIRVTPGMLADEAYGIKTSSADLLRFVKANIGGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYAYPVSEQTLLAGNSPAMIYNAIPAVPAPAAAGHPVLFNKTGSTNGFGAYVAFVPAKGIGIVMLANRNSPIEARIKAAHAILTQLAR	162.66	gnl|BL_ORD_ID|1507|hsp_num:0	1637			612	831	
BGC0000254.1|Oxytetracycline_6 # 5521 # 6777 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=ACGGCG;rbs_spacer=13bp;gc_cont=0.731	BGC0000254.1|Oxytetracycline_6 	5521	6777	+	Loose	600	80.4925	Streptomyces venezuelae rox	28.67	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA	MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	87.82	gnl|BL_ORD_ID|4833|hsp_num:0	5820			6	1149	rifampin; rifaximin; rifapentine
BGC0000254.1|Oxytetracycline_7 # 6809 # 7807 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=ACGGCG;rbs_spacer=15bp;gc_cont=0.733	BGC0000254.1|Oxytetracycline_7 	6809	7807	-	Loose	500	33.8834	chrB	39.13	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGCGGCTGCGCGAACTCGCCCTGAGCGCCGCCTGTGCCGCCGCCGTCCGCGCCGCGGCGAGCCTGGGCGTCGCGGACGCCCTCGGGGACGAACCCGCGGACGCCGGCACCCTCGCGAAGGCGGTGCGGGCCGACGCGGACGCGCTGGAGCGCCTGCTGCGCGCCCTCGCCGCGTACGACGTCTTCAGCGAACTCCCCGACGGCCGCTTCGAGCACACCGACGCCTCCCGGCTGCTGCGCGAGGACGCCCCGCGCGGCCTGCGCTACTCGGCGCTGTGGGCGACCGAGCCGTGGACCTGGGCGCTGTGGCCGCACCTGGCGGACGCCGTGCGCACCGGCCGGGAGGAGTTCACCGCGCTGTACGGCACCGAGTTCTTCGACTGGCTGCACACCGCCGAGGCCCGCGAGTCGGCCGAGGTGTTCGACAAGGCCATGACCCAGTCCAGCGTGCTGTCGGCGAAGGCCATCGCCGAGGTGCTCGACCTGGACGGCGTCGGCGCCATGGTGGACATCGCCGGGGGCCAGGGCATGGTGCTCGCCACCCTGCTGGAGAAGTACCCGGCGCTGCGCGGCACCCTCTTCGACCTGCCGAAGGTCGTCGCCGACGCCGACCCGCGGCTGCGCGAGGGCGGCGCGCTCGCCGGGCGCGCGCAGCTGGTGGGCGGTGACTGCCGGCAGTCGGTGCCGGAGGGTGCCGACCTGTATCTGCTGAAGAACATCCTGGAGTGGGACGACGAGAGCACGGTGCGCACCCTGCGCAACGTCGCCAAGTCGGCCCCCGCCGGGGCGCGCGTCGTGGTGGTGGAGAACCTGGTCGACGGCAGTCCCGAGACCCGGTTCACCACCGCCATGGACCTGATGCTGCTGCTCAACGTCGGCGGCAAGAAGCACACCAAGGCGGGGCTGAGCGCGCTGGTGGAGCAGGCGGGGCTCCAGCTGGAGGAGGTACGCGCGGTCAACTCCTACCTGCACATGTTCGTGAGCACGGTGCCCGCGTAG	MRLRELALSAACAAAVRAAASLGVADALGDEPADAGTLAKAVRADADALERLLRALAAYDVFSELPDGRFEHTDASRLLREDAPRGLRYSALWATEPWTWALWPHLADAVRTGREEFTALYGTEFFDWLHTAEARESAEVFDKAMTQSSVLSAKAIAEVLDLDGVGAMVDIAGGQGMVLATLLEKYPALRGTLFDLPKVVADADPRLREGGALAGRAQLVGGDCRQSVPEGADLYLLKNILEWDDESTVRTLRNVAKSAPAGARVVVVENLVDGSPETRFTTAMDLMLLLNVGGKKHTKAGLSALVEQAGLQLEEVRAVNSYLHMFVSTVPA	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	118.57	gnl|BL_ORD_ID|274|hsp_num:0	305			270	408	tylosin; chalcomycin; mycinamicin
BGC0000254.1|Oxytetracycline_8 # 7899 # 9833 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.733	BGC0000254.1|Oxytetracycline_8 	7899	9833	-	Loose	1000	53.9138	almE	25.0	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGGCCGAGCGCCACCCCGAGGGCCCGCAGGACAGCACCGCCGAGGGGCCGCCGCTCGACGTGCTGGCGCAGTTGACGGGCGGCCCGCGCATCGACGACGTGCTGTCGCGGGCGGCCCGCCGCGCCCCCAGACGGCTCGCGCTGAGCGGCCCCTCAGGGGACCTGACCTACGCGGCCCTGGAGGAGCGGGCGACGCGGTGCGCCGCCGCGCTGCGCGAACTGGACGGTGAACCCGGCGCGGTGGTGGGCATCGCCGCCGTACTGGACACCTCGTTCGCCGTGGCGTACTTCGGCGCCTCCCGGGCCCGGCACGTCAGCGCGATGTTCAACCCGCTGCTGCGCGAGGAGCGCCTGACGCACGTGCTGCGCTCGGCGGGCGCGCGGACCGTGATCGTCCCGCCGGAGATGTACGCGCGTATCCAGGCCGTACGAGGGGACCTGCCGGCGTTGCGGACCGTGGTGCTCACCCACCGCGAGGCCGGCTTTCAGGAGGCCACGGCCGACGTGCCCACGCTCGACGAGCTGATCGACGCGGCCCCCGCCACGGCGCCGTTCGCCGGCCGCGACCCCGAGGGCGTGGCCAACCTCCAGTTCACCAGCGGCACCACCGGCGCCCCGAAGACCGTCATGCTCACCCACCGCAACCTGACGGTGAACGCGGCCCAGACCGCGTACACCCACCGGCTCACCCCCGAGTCGGTGCTGCTCAACACCCTGCCGTCGTTCCACCTGATGCACCTGAACATCGCGGTGACCGTCGGCGCCACCCACCTGCTGCGGCCCGGCGACGACACCGTGGCCGCACTGCGCGAGGGCGCCCGCCACGGCGCGACGCACCTCTACAGCCTGCCGGTACGGCTGGCCCGGCTGGCGGCGGACGACCGGCTGCCGGAACTGTCCGTGCCCAGCCTGCGGGCCGTGCTCTCCGGCGGATCGGCCCTGCCCGCGCGGACCGCCGATGTCCTGGGCGGGCACTTCGGCGTCCCGGTCGTCCAGGGGTACGGACTGGCCGAGACCGCGCCGTCCACGCACTTCGACGACCTGGACCACCCGGTGGCCGGCTCGTCGGGCAGGCCCGTACCGGGCACCGCCTGCCGGATCGTGGACCTGCGGACCCGCGCCGTCCTCCCGGTGGGCGGCCGCGGCGAGATCCAGGTCAAGGGGCCCCAGCTGATGAAGGGGTACCTCGGCCGGCCGCGGGAGGAGTCCGTGGACCCGGACGGCTGGTTCTCGACCGGCGACATCGGCGAGACCGACGCGGAGGGGCGGCTGTTCGTCGTCGACCGGGTCAAGGACGTCTTCAAGTGCGACAACTGGCTGGTCTCGCCCCTGGAGATCGAGAACGTGCTGGCCCGCTGCCCCGGGGTGACGGACTGCGCGGTCTTCGACCACCCGGACGAGTTGAGCGGCGCCGTCGCGCACGCGCTGGTGGTCCTGGCGGACGAGGCCGCCGACCGCGACGCCGTCATCCGCTTCGTCAACGACCAGCTGCCCTACTACCAGCACATCAAGTACCTCGACGTCGTACGGCACATCCCGCGCTCGCCCACCGGCAAGATCCAGCGCCGCGACCTGCGGGAGCAGACCCTCGGCGGCACCCGGAAGCACGCCACGGGCGCCACCCATCACACGAAGGGCACCTCCACCATGTTCACCTTCATCAACCGGTTCACGGTCCAGGGCGACGCCGCCGAGTTCGAGAAGCGGGTCGGTGAGATCACCGCCCATATGTCGCGGCAGCCCGGCTTCCGCTCGCACCGCCTGCTGCGCTCCGCCAAGGACCCGCAGGTCTATGTCGAGATCGCCGAGTGGGACGACGCCGAGTCGCACGGCCGCGCGCTGCGCACCGAGACGTTCCAGCAGGCCGTGAGCGAGGTCAAGAAGCTCGCGAGCGCCGACCCGGCCCCGTTCGTCCCGGTCACCGCGGCCGGCTGA	MAERHPEGPQDSTAEGPPLDVLAQLTGGPRIDDVLSRAARRAPRRLALSGPSGDLTYAALEERATRCAAALRELDGEPGAVVGIAAVLDTSFAVAYFGASRARHVSAMFNPLLREERLTHVLRSAGARTVIVPPEMYARIQAVRGDLPALRTVVLTHREAGFQEATADVPTLDELIDAAPATAPFAGRDPEGVANLQFTSGTTGAPKTVMLTHRNLTVNAAQTAYTHRLTPESVLLNTLPSFHLMHLNIAVTVGATHLLRPGDDTVAALREGARHGATHLYSLPVRLARLAADDRLPELSVPSLRAVLSGGSALPARTADVLGGHFGVPVVQGYGLAETAPSTHFDDLDHPVAGSSGRPVPGTACRIVDLRTRAVLPVGGRGEIQVKGPQLMKGYLGRPREESVDPDGWFSTGDIGETDAEGRLFVVDRVKDVFKCDNWLVSPLEIENVLARCPGVTDCAVFDHPDELSGAVAHALVVLADEAADRDAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRKHATGATHHTKGTSTMFTFINRFTVQGDAAEFEKRVGEITAHMSRQPGFRSHRLLRSAKDPQVYVEIAEWDDAESHGRALRTETFQQAVSEVKKLASADPAPFVPVTAAG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	115.83	gnl|BL_ORD_ID|4935|hsp_num:0	5928			537	1659	colistin A; colistin B
BGC0000254.1|Oxytetracycline_9 # 9872 # 10324 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=CGCCG;rbs_spacer=14bp;gc_cont=0.744	BGC0000254.1|Oxytetracycline_9 	9872	10324	-	Loose	260	23.483	FosD	29.03	3004674	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGACCGCCCCGGAACAGCCCTCGGGCGTCCCCGTGGACACCGCGCTCTACCAGGAGATCCAGCACTTCTACGGACGCCAGATGCGCTGCCTGGACGAGGCGCGGGTCGAGGAGTGGGCCGGCACCTTCACCGAGGACGGCGTCTTCGTCGCCAACGCCCACCCCGAGCCGTCCGTCGGGCGGGCCGCCATCGCGGCCGGGGCCCGCAAGGCCGCCGCCCTGCTGGCCGAGCAGGGCGTCCAGCGCCGCCACTGGCTCGGCATGCTGGACGCCGACGCCTGTGACGACGGCACCGTCCGCGCCCGCACCTACGCCCTGATCATCAGCACGCCGCGCGGCGGCCAGGCCGCGGTGCACCTGAGCACGAGCTGCGACGACGTGCTCGTACGGGAGGACGGCCAACTGCGCGTACGGCACCGCGAGGTGCGCCGGGACGACCTGCGGCCCGAGTAG	MTAPEQPSGVPVDTALYQEIQHFYGRQMRCLDEARVEEWAGTFTEDGVFVANAHPEPSVGRAAIAAGARKAAALLAEQGVQRRHWLGMLDADACDDGTVRARTYALIISTPRGGQAAVHLSTSCDDVLVREDGQLRVRHREVRRDDLRPE	MIQSINHICYSVSDLKNSIRFYKNILCGELLVSGKTTAYFNIGGLWVALNEEKDIPRNEVQYSYTHVAFTIDESEFNDWYQWFKENDVNILEGRTRDVRDKQSIYFTDPDGHKLELHTGTLENRLNYYKETKPHMVFYK	107.91	gnl|BL_ORD_ID|2251|hsp_num:0	3373			171	264	fosfomycin
BGC0000254.1|Oxytetracycline_10 # 10593 # 11384 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722	BGC0000254.1|Oxytetracycline_10 	10593	11384	+	Loose	450	35.8094	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	22.95	3004045	protein variant model	F203A	n/a	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	ATGACTACCAGTGCCACGCCCAGGACCGCCCTGGTGACGGGCGGCACCAGCGGCATCGGGCTCGCCGTGGTGAAGACGCTCGCCGCCCGCGGGCTGCGGGTGTTCCTGTGCGCCCGCAGCCGCGAGAACGTCGACGCCGTGGTCAAGGAACTGCGCGACCAGGGGCTTCAGGTGGCCGGGTGCGAGGGGGACGTGCGGTCCCGGGAGTCGGTGGAGCGGGTGGTGCGCGCCGCGGTCGACCGGTTCGGGCCGCTGAGCGTCCTGGTGAACAACGCGGGGCGCAGCGGCGGCGGAGTGACCGCGCGCATCCCCGACGAGCTCTGGTACGACGTGATCGACACCAACCTCAACAGCGCCTTCCTGGTCACCCGTGAGGCCCTGACCACCGGCGGGCTGGAGCGGGCGGGCGTCGACGGGCGGATCATCAGCATCGCCTCCACCGGCGGCAAGCAGGGCGTTCCGCTGGGCGCCCCCTACTCGGCCTCGAAGGCGGGCCTGATCGGTTTCACCAAGGCGCTGGCCAAGGAGCTGGCCCCCACGGGGGTCACCGTCAACGCCGTGTGCCCGGGGTACGTGGAGACGCCGATGGCCGTCCGCGTACGGCAGGCGTACGCGGCCACCTGGGACACCACCGAGGAGGACGTGCTGTCCCGCTTCAACGACAAGATCCCGCTGGGGCGCTACTCCACACCCGAGGAGGTGGCCGCCCTGGTCGGCCACCTGGCGGGCGACGAGGCCGGGTCCATCACCGCGCAGGCCCTCAACGTCTGCGGCGGGCTGGGCATTTACTGA	MTTSATPRTALVTGGTSGIGLAVVKTLAARGLRVFLCARSRENVDAVVKELRDQGLQVAGCEGDVRSRESVERVVRAAVDRFGPLSVLVNNAGRSGGGVTARIPDELWYDVIDTNLNSAFLVTREALTTGGLERAGVDGRIISIASTGGKQGVPLGAPYSASKAGLIGFTKALAKELAPTGVTVNAVCPGYVETPMAVRVRQAYAATWDTTEEDVLSRFNDKIPLGRYSTPEEVAALVGHLAGDEAGSITAQALNVCGGLGIY	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	100.38	gnl|BL_ORD_ID|4712|hsp_num:0	2666			420	759	triclosan
BGC0000254.1|Oxytetracycline_11 # 11443 # 12396 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.724	BGC0000254.1|Oxytetracycline_11 	11443	12396	+	Loose	750	26.5646	Yrc-1	26.17	3005035	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	YRC Beta-lactamase	ATGCCCGCACCCACATCCCACCGCGCCGTGCACCGCACGGAGATCGACGCCCCGGCCGACCGGGTGTACGCCCTGATCAGGGACGCCGCCGAGTGGCCCCGGCACTTCACCCCGACCGTCCACGTCGAGCGCGCGGAGCTCGACGCCCGCAGCGAGCGGCTGCGGATCTGGGCCACCGCCAACGGCGAGGTCAAGCACTGGACGTCGCACCGCGCCCTGGACCCCGAAGGGCAGAGCGTCCGGTTCCGGCAGGAGGTGTGTTCGCCTCCGGTGGCCGCGATGAGCGGTGAATGGGTCCTCCGGGACCTTCCGGGCGGGCGGTGCGAGCTGACGCTGCACCACACGTTCGCCGCGGTGGACGACCGCCCGGAGGACGTGGAGTGGATCACCACCGCGACCGACCGCAACAGCCGTACCGAGCTGGCGAACATCAAGGCGCTGGCCGAGGCCGCGGGGTCCGACGCGGAGCTGCTGTTCTCGTTCGAGGACTCCGAGACGGTGCACGCCCCGGCCGAGGCGGTGTACGCGTTCCTCGCGGAGGCCGGGAAGTGGCCCGACCGGCTGCCGCACGTCTCCCGGCTCGACCTCACCGAGCCGTCCGACGGCGTGCAGGTGATGACCATGGTCACCCGGGCCAACGACGGCTCGGAGCACACGACGGAGTCGGTGCGGGTCTGCTTCCCCGACGAACTGCGCATCGTCTACAAGCAGATCGGCACCCCGCCGCTGATGACCCTGCACACCGGTGAGTGGTCGATACGGGACACCGGGGACGGGCTGCTCGTCACCTCCCAGCACACCATCCGGATCAACGAATCCGCCATCCCGGAGATCCTCGGCGCGGACGCCACGGCGGCCGACGCGCGGGCCCGGGTGCGCGCGGCGGTCGGCGGCAACAGCGCGGCCACCCTGGCCCTCGCCAAGCGCTTCGCGGAGGCCCCGCATGCCGCCTGA	MPAPTSHRAVHRTEIDAPADRVYALIRDAAEWPRHFTPTVHVERAELDARSERLRIWATANGEVKHWTSHRALDPEGQSVRFRQEVCSPPVAAMSGEWVLRDLPGGRCELTLHHTFAAVDDRPEDVEWITTATDRNSRTELANIKALAEAAGSDAELLFSFEDSETVHAPAEAVYAFLAEAGKWPDRLPHVSRLDLTEPSDGVQVMTMVTRANDGSEHTTESVRVCFPDELRIVYKQIGTPPLMTLHTGEWSIRDTGDGLLVTSQHTIRINESAIPEILGADATAADARARVRAAVGGNSAATLALAKRFAEAPHAA	MMHKTLSCALLLVASGSTFATPQTEKKLSGIVDNVVIPLMKEQAIPGMAVAVIYQGQPYYFTWGMADVAGKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPVSKYWPALSGKQWEGISLLNLATYTAGGLPLQVPDNITDETSLQNYYETWQPQWAPGTKRFYSNASIGMFGKLAVKPSGMSFEQAMNKRVFQPLNLTHTWIHVPEREEKHYAWGYRDGKAVHVSPGMLDAEAYGVKSSIKDMASWVRANMTPSEVKDASLQKGILLAQSRYLQVGDMYQGLGWEMLNWPMKATIAVGGSDNKVALAPLSAVEINPPAPALNSSWVHKTGSTGGFGSYVAFIPEKNLGIVMLANKSYPNPARVEAAYRILEALSVE	82.77	gnl|BL_ORD_ID|2767|hsp_num:0	3779			678	999	cefoxitin; ceftazidime; cefuroxime; amoxicillin; cefalotin
BGC0000254.1|Oxytetracycline_12 # 12386 # 14059 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.743	BGC0000254.1|Oxytetracycline_12 	12386	14059	+	Loose	550	157.147	Nocardia farcinica rox	36.06	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA	MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	117.76	gnl|BL_ORD_ID|4834|hsp_num:0	5821			6	1029	rifampin
BGC0000254.1|Oxytetracycline_13 # 14056 # 14835 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=CGCCG;rbs_spacer=15bp;gc_cont=0.742	BGC0000254.1|Oxytetracycline_13 	14056	14835	+	Loose	500	42.743	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid	29.28	3003393	protein variant model	S94A	n/a	isoniazid-like antibiotic	antibiotic target alteration	isoniazid resistant inhA	ATGACCAAGGAGGACACGCGTATGACAGCGATCAACGGCGCACCGGCGGCAGGCGGTTCGGTGGCACTGGTCATCGGCGGCACCCGCGGCATCGGGCTGGCCGCCGCCCGCAAACTGAGCGCGGCGGGCAGCGAGGTGCTGCTCAACTACGCGCACGACGAGGACGGCGCGCTGGCGGCCGAACGGCAGCTGTCCGAGGAGGGCGGCAAGGTACGGCTGATGCGCGCGGACATCGGCCGCCCCGCCGGTGTGGTGCGGCTGCTGGAGGACATCCGGCGCACCCACGGCCGGCTGGACGTCCTGGTGCACGCAGCCGGTTCCTTCCATCCGGCGCCGACCGCGTCCCCGCACATCGGCAAGTACCTGGGCGACGGCGCCGTGGCGGTCGGACCGCTGCTGTACGGGGCGGCGCGCCTGGGCACCCTGATGACCCCGGACACGGGCCGTATCGTCGCCGTCTCCAGCATCGGCGCCCGGACGGTCGTCCCCGGCTACGCGGGTCTGGGCATGGCCAAGGCGGCCTTGGAGACGCTGGTGCGGTACCTGGCGGTGGAACTCGCCGGGAAGGGCGTCGCGGTGAACGCGGTGGCCGCGGGCAAGATCGCCGACGGCGGTCCCGTACCGGCCCAGGTACTGGAGGGCCTGCTGCGGCGGACCCCGACGGGGCGGCTGGCGACTGCCGAAGAGGTGGCCGACGTGGTGGCGCTGCTGTGCCGCCCCGAGGCCGGCGGCCTGCACGGACAGGTGCTCACCGTGGACGGCGGGGCCTGCCTGCGGTAG	MTKEDTRMTAINGAPAAGGSVALVIGGTRGIGLAAARKLSAAGSEVLLNYAHDEDGALAAERQLSEEGGKVRLMRADIGRPAGVVRLLEDIRRTHGRLDVLVHAAGSFHPAPTASPHIGKYLGDGAVAVGPLLYGAARLGTLMTPDTGRIVAVSSIGARTVVPGYAGLGMAKAALETLVRYLAVELAGKGVAVNAVAAGKIADGGPVPAQVLEGLLRRTPTGRLATAEEVADVVALLCRPEAGGLHGQVLTVDGGACLR	MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGAHTQLL	96.28	gnl|BL_ORD_ID|1964|hsp_num:0	1574			255	792	isoniazid
BGC0000254.1|Oxytetracycline_14 # 14855 # 15628 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGCGC;rbs_spacer=15bp;gc_cont=0.711	BGC0000254.1|Oxytetracycline_14 	14855	15628	+	Loose	1800	25.7942	mdtB	35.71	3000793	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGCATCATCGATCTGTCGACAACCGTGGACGCCGGCCGGTGGGAGGTCGATCCGGTCGAACACGAAATCCTCACCCCGGCCGAGGGCGGCCGGCACATGGCCGAGGGGATGCGGCGCCACCACGGCATCGACTTCGACCCCGCCGACCTCCCGGACGGCGAACTGCTGTCCCTCGACACCCTGCGGCTGACCACCCACACCGGCACCCACGTCGACGCCCCGTCGCACTACGGGTCCCGCGCGCGCTACGGCACGCCGCGCCACATCGACCAGATGCCACTGGACTGGTTTCTGCGGCCGGGCCTCAAGCTCGACCTTACCGACGAGCCGGTGGGCGCCATCGGAGCCGACCGGATACGGCGGGCCCTCGACGAAGCGGGCCGCGACCCGCGTCCGTACGACATCGTGCTGCTGCACACCGGCGCGGACCGGCGGGCCGGAAAGCCGGAGTACTTCACCGAGTTCGCCGGCCTGGACGCCGCGGCGACCCACCTGCTGCTCGACTTCGGCGTCCGGGTCATCGGCACCGACGCCTTCAGCCTCGACGCCCCGTTCGGGCACATGATCAAGGAGTACCAGCGCACCGGCGACCGCGGTGTGCTGTGGCCCGCCCACTTCGTGGGACGGGAGCGCGAGTACTGCCAGATCGAGCGGCTGGACAACCTCGGCGCGCTGCCCGGACCGGACGGCTTCTTGGTCTCCTGCTTTCCGTTCAAGATCGCGGGAGCGGGGGCGGGGTGGACGCGGGCGGTGGCGGTGGTGGAGGAGTAG	MRIIDLSTTVDAGRWEVDPVEHEILTPAEGGRHMAEGMRRHHGIDFDPADLPDGELLSLDTLRLTTHTGTHVDAPSHYGSRARYGTPRHIDQMPLDWFLRPGLKLDLTDEPVGAIGADRIRRALDEAGRDPRPYDIVLLHTGADRRAGKPEYFTEFAGLDAAATHLLLDFGVRVIGTDAFSLDAPFGHMIKEYQRTGDRGVLWPAHFVGREREYCQIERLDNLGALPGPDGFLVSCFPFKIAGAGAGWTRAVAVVEE	MQVLPPSSTGGPSRLFIMRPVATTLLMVAILLAGIIGYRALPVSALPEVDYPTIQVVTLYPGASPDVMTSAVTAPLERQFGQMSGLKQMSSQSSGGASVITLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSTAMPMTQVEDMVETRVAQKISQISGVGLVTLSGGQRPAVRVKLNAQAIAALGLTSETVRTAITGANVNSAKGSLDGPSRAVTLSANDQMQSAEEYRQLIIAYQNGAPIRLGDVATVEQGAENSWLGAWANKEQAIVMNVQRQPGANIISTADSIRQMLPQLTESLPKSVKVTVLSDRTTNIRASVDDTQFELMMAIALVVMIIYLFLRNIPATIIPGVAVPLSLIGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAITLAVAILISAVVSLTLTPMMCARMLSQESLRKQNRFSRASEKMFDRIIAAYGRGLAKVLNHPWLTLSVALSTLLLSVLLWVFIPKGFFPVQDNGIIQGTLQAPQSSSFANMAQRQRQVADVILQDPAVQSLTSFVGVDGTNPSLNSARLQINLKPLDERDDRVQKVIARLQTAVDKVPGVDLFLQPTQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLMEKLQQLPQLSDVSSDWQDKGLVAYVNVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEHNTENTPGLAALDTIRLTSSDGGVVPLSSIAKIEQRFAPLSINHLDQFPVTTISFNVPDNYSLGDAVQAIMDTEKTLNLPVDITTQFQGSTLAFQSALGSTVWLIVAAVVAMYIVLGILYESFIHPITILSTLPTAGVGALLALLIAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMSPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLIVSQVLTLFTTPVIYLLFDRLALWTKSRFARHEEEA	24.71	gnl|BL_ORD_ID|757|hsp_num:0	820			2319	2445	novobiocin
BGC0000254.1|Oxytetracycline_15 # 15893 # 16795 # 1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.715	BGC0000254.1|Oxytetracycline_15 	15893	16795	+	Loose	400	65.855	qnrE2	26.88	3004637	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA	MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF	MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRASQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKLDSYQVSQLMERLGIVVLG	140.19	gnl|BL_ORD_ID|2119|hsp_num:0	3336			75	543	ciprofloxacin; levofloxacin; moxifloxacin; gatifloxacin; nalidixic acid; norfloxacin; sparfloxacin
BGC0000254.1|Oxytetracycline_17 # 17832 # 18881 # -1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=CCC;rbs_spacer=15bp;gc_cont=0.739	BGC0000254.1|Oxytetracycline_17 	17832	18881	-	Loose	400	28.4906	kdpE	58.06	3003841	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	kdpDE	GTGCTGCTGCCGTACAAGAAGCGCGCCGCGGCCCACCCCGACGGGCTGGTCAACCTGGCGCTGGGCGAACCGGTCGACGCCACGCCCGACGTGCTGCGCGACGCCCTCGCGGCGGCGACCGACGCGCCCGGCTACCCGCCCACGGAGGGGACGCCCGCGCTCCGCGAAGCGGCCGCCGCATGGCTGCGCCGCCGCCTGGGCGTGACGGTGGACCCCTCGGCCGTACTGCCCGCGGTCGGCACCAAGGAGCTGATCGCCTGGCTCCCGGCGATGCTGGGCACCGGCCCCGGCGACACGGTGGCCTTTCCCCGGCTGGCGTTTCCCACCTTCGACGTCAGCGCGCGCCTCGCGGGCGCGCGGGGGCGCCCGGTGGATTCACCGCTGGAGCTCGGCAGTGAACCGGTCAAGGTGGTCTGGCTCAACTCGCCGTCCAACCCGGAGGGCCGGGTGCTGTCCGTACCCGAGCTGCGCGAGATCGTGGCCTGGGCGCGGGACCGGGGCGCCGTCCTCGTCAACGACGAGTGCTACATCGAATACGGGTGGGACCGGCGGCCGGTGTCGCTGCTGGACTCGGCGGTGTGCGGCGGCAGTCACGATGGTCTGCTGGCGGTGCACTCGCTGTCCAAGCGGTCCAACCTCGCGGGCTACCGCGCGGGCGTCTGCTCCGGCGACCCGGCCCTGATCGGGCGCCTCCTCCAGGTACGCAAGCACGCCGGGCACGCGGTCCCGGCCCCCGTACAGGCGGCCATGGTGGCCGCCCTGGAGGACGACGCCCACGTGGAGCGGCAGCGAGACCGGTACGCCTACAGGCGGCGCGTTCTGCGCACGGCCCTGGAGGGGGCCGGGTTCCGCGTCGAGCATTCCGAAGGCGGCCTGTTCCTGTGGGCCACCCGGGGTGAGCCCTGCTGGCCCGCCGTACAGAAGCTGGCCGATCTCGGCATCCTCGTCGCACCCGGTGCCTTCTACGGCGAGGCCGGTGAGCAGTACGTACGGATTGCGTTCACGGCGACCGACGAACGCATCGCCGCGGCCGCCGCCCGGCTGACATGA	MLLPYKKRAAAHPDGLVNLALGEPVDATPDVLRDALAAATDAPGYPPTEGTPALREAAAAWLRRRLGVTVDPSAVLPAVGTKELIAWLPAMLGTGPGDTVAFPRLAFPTFDVSARLAGARGRPVDSPLELGSEPVKVVWLNSPSNPEGRVLSVPELREIVAWARDRGAVLVNDECYIEYGWDRRPVSLLDSAVCGGSHDGLLAVHSLSKRSNLAGYRAGVCSGDPALIGRLLQVRKHAGHAVPAPVQAAMVAALEDDAHVERQRDRYAYRRRVLRTALEGAGFRVEHSEGGLFLWATRGEPCWPAVQKLADLGILVAPGAFYGEAGEQYVRIAFTATDERIAAAAARLT	MTNVLIVEDEQAIRRFLRTALEGDGMRVFEAETLQRGLLEAATRKPDLIILDLGLPDGDGIEFIRDLRQWSAVPVIVLSARSEESDKIAALDAGADDYLSKPFGIGELQARLRVALRRHSATTAPDPLVKFSDVTVDLAARVIHRGEEEVHLTPIEFRLLAVLLNNAGKVLTQRQLLNQVWGPNAVEHSHYLRIYMGHLRQKLEQDPARPRHFITETGIGYRFML	155.11	gnl|BL_ORD_ID|2103|hsp_num:0	2331			39	132	kanamycin A
BGC0000254.1|Oxytetracycline_18 # 18908 # 19336 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.706	BGC0000254.1|Oxytetracycline_18 	18908	19336	-	Loose	150	36.965	nimG	26.73	3007109	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic inactivation	nitroimidazole reductase	ATGCCGTTCACCCAGAAGGAAATCACCTACCTGCGCGCGCAGGGCTACGGCCGTCTGGCGACGGTCGGCGCCCATGGAGAACCCCACAACGTGCCCGTCTCGTTCGAGATCGACGAGGAGCGCGGCACCATCGAGATCACCGGCCGGGACATGGGCCGCAGCCGCAAGTTCCGGAACGTGGCGAAGAGCGACCGGGTCGCCTTCGTCGTGGACGACGTGCCGTGCCGCGACCCCGAGGTGGTCCGCGCCGTCGTCATCCACGGCACGGCCCAGGCGCTGCCCACCGGCGGCAGGGAGCGCCGGCCGCACTGCGCCGACGAGATGATCCGCATCCACCCCCGGCGCATCGTCACCTGGGGCATCGAAGGGGACCTGTCCACCGGGGTCCACGCACGCGACATCACGGCCGAGGACGGAGGACGGCGATGA	MPFTQKEITYLRAQGYGRLATVGAHGEPHNVPVSFEIDEERGTIEITGRDMGRSRKFRNVAKSDRVAFVVDDVPCRDPEVVRAVVIHGTAQALPTGGRERRPHCADEMIRIHPRRIVTWGIEGDLSTGVHARDITAEDGGRR	MFREMRRKRQLLSTKESVAILERMTNGTLALHGDDGYPYAVPVSYVYADGKIYFHSAMKGHKVDAISRNDKISFCVVEQDDIKPSEFTTYFRSVIVFGKARILTDEGEKRVALGLLADKYSHGEAGMEAEIAKGFNHLLMVEITVEHMTGKESIELIKERNDCS	86.59	gnl|BL_ORD_ID|4786|hsp_num:0	5782			39	330	metronidazole
BGC0000254.1|Oxytetracycline_19 # 19438 # 21003 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=CCGGC;rbs_spacer=15bp;gc_cont=0.735	BGC0000254.1|Oxytetracycline_19 	19438	21003	+	Loose	550	375.17	Nocardia farcinica rox	47.69	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA	MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	110.15	gnl|BL_ORD_ID|4834|hsp_num:0	5821			6	1410	rifampin
BGC0000254.1|Oxytetracycline_20 # 21064 # 22098 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=CCC;rbs_spacer=15bp;gc_cont=0.722	BGC0000254.1|Oxytetracycline_20 	21064	22098	+	Loose	400	32.7278	ErmS	29.09	3001304	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACCACCACACCGCTCGCCCCCGTGGCCCAGGCCCGCTCGCTGCTGCAGCTGACCACCGCGTACCACCAGGCGAAGGCCCTGCACAGCGCCGTGGAGCTGGGCCTGTTCGACCTGCTCGCCGACGGGCCCGCGACCGCCGAGGAGGTGAAGGACCGGCTGCGGATCGTCCATCCGCTGGCCAAGGAGTTCCTCGACGCGCTCGTCGCGCTGGAGTTGCTGGAAGCGGACGGCGACCGCTACCGCAACTCCCCCGCCGCCCAGGCGTTCCTGGTGTCCGGCGCCTCCGAATACCTGGGCGGCACCGTCCTCCAGCACGCCCGCAAGCACTACCACGTATGGGCCGGGCTGACGACGGCGCTCCAGGAGGGCGAGGCGGGTTCCGGCGCCGAAGCGCACGGGCCCGAGGCGTACCCCAAGCACTACGAGGACCCGGAGCGGGCCCGTCAGGTCATGGCGCACTTCGACACCTTCAGCTCCTTCACGGCCGAGGAGCTGGCGCGCCGCGTCGACTGGAGCGGGTACGGGTCCTTCATCGACATCGGCGGCGCACGGGGCAACCTCGCCACGCGGGTGGCCCTGGCCCACCCGCACCTGCACGGCGCCGTGTTCGACCTGCCCGCGCTGGCCCCGCTGGCCGGCGAGCTGATCCGTGAGCGCGGCCTCGAAGGCCGCGTCCGCTTCCACGGCGGCGACTTCCTGACCGACCCGCTGCCGTCCGCGGACGCCGTGGTCACCGGGCACGTACTGCCCGACTGGCCGGTACCGCAGCGGCGCAAGCTCCTCGCGCGCATCCACGAGGCGCTGCCCTCCGGCGGCGCGCTGGTGGTCTACGACCTGATGACGGATCCGGCCACCACGACGGTGCACGACGTACTGCAACGGCTCAACCACGGCCTCATCCGCGGCGACAGCTCGTCCAGCAGCGTCGAGGAGTACCGCGCGGAGATCGAGGAGGCCGGCTTCCGGGTGCGGCAGGCGGAGCGCATCGACAACCTCCTCGGTGACTGGCTGATAGTCGCCGTCAAGCCCTGA	MTTTPLAPVAQARSLLQLTTAYHQAKALHSAVELGLFDLLADGPATAEEVKDRLRIVHPLAKEFLDALVALELLEADGDRYRNSPAAQAFLVSGASEYLGGTVLQHARKHYHVWAGLTTALQEGEAGSGAEAHGPEAYPKHYEDPERARQVMAHFDTFSSFTAEELARRVDWSGYGSFIDIGGARGNLATRVALAHPHLHGAVFDLPALAPLAGELIRERGLEGRVRFHGGDFLTDPLPSADAVVTGHVLPDWPVPQRRKLLARIHEALPSGGALVVYDLMTDPATTTVHDVLQRLNHGLIRGDSSSSSVEEYRAEIEEAGFRVRQAERIDNLLGDWLIVAVKP	MARAPRSPHPARSRETSRAHPPYGTRADRAPGRGRDRDRSPDSPGNTSSRDGGRSPDRARRELSQNFLARRAVAERVARLVRPAPGGLLLEVGAGRGVLTEALAPYCGRLVAHEIDPRLLPALRDRFGGPHHAHVRISGGDFLAAPVPREPFALAGNIPYSRTAGIVDWALRARTLTSATFVTQLEYARKRTGDYGRWSLLTVRTWPRHEWRLLGRVSRREFRPVPRVDSGILRIERRERPLLPSAALGDYHRMVELGFSGVGGSLYASLRRAHRAGPLDAAFRAARLDRSVVVAYVTPEQWLTVFRTLRPVRSRPAGR	107.84	gnl|BL_ORD_ID|671|hsp_num:0	727			159	474	lincomycin; tylosin; pristinamycin IC; carbomycin; niddamycin
BGC0000254.1|Oxytetracycline_21 # 22257 # 23312 # 1 # ID=1_21;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.721	BGC0000254.1|Oxytetracycline_21	22257	23312	+	Strict	275	688.723	Streptomyces rimosus otr(A)	100.0	3002891	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAACAAGCTGAATCTGGGCATCCTGGCCCACGTTGACGCCGGCAAGACCAGCCTCACCGAGCGCCTGCTGCACCGCACCGGTGTGATCGACGAGGTCGGCAGCGTGGACGCCGGCACCACGACGACCGACTCGATGGAGCTGGAGCGGCAGCGCGGCATCACCATCCGGTCCGCCGTGGCCACGTTCGTCCTGGACGATCTCAAGGTCAACCTCATCGACACCCCGGGCCACTCCGACTTCATCTCCGAGGTCGAGCGGGCGCTCGGGGTGCTCGACGGCGCGGTCCTGGTGGTCTCGGCCGTCGAGGGCGTCCAGCCGCAGACCCGCATCCTGATGCGGACCCTGCGCAGGCTGGGCATTCCCACGCTGGTCTTCGTCAACAAGATCGACCGGGGCGGCGCGCGTCCCGACGGTGTGCTGCGGGAGATCCGCGACCGGCTCACCCCCGCCGCGGTGGCACTGTCCGCCGTGGCGGACGCCGGCACGCCGCGGGCCCGCGCGATCGCGCTCGGCCCGGACACCGACCCGGACTTCGCCGTCCGGGTCGGTGAGCTGCTGGCCGACCACGACGACGCGTTCCTCACCGCCTACCTGGACGAGGAACACGTACTGACCGAGAAGGAGTACGCGGAGGAACTGGCCGCGCAGACCGCGCGCGGTCTGGTGCACCCGGTGTACTTCGGGTCCGCGCTGACCGGCGAGGGCCTGGACCATCTGGTGCACGGCATCCGGGAGTTGCTGCCGTCCGTGCACGCGTCGCAGGACGCGCCGCTGCGGGCCACCGTGTTCAAGGTGGACCGTGGCGCGCGCGGCGAGGCCGTCGCGTACCTGCGGCTGGTCTCCGGCACGCTGGGCACCCGCGATTCGGTGACGCTGCACCGCGTCGACCACACCGGCCGGGTCACCGAGCACGCCGGACGCATCACCGCGCTGCGGGTCTTCGAGCACGGGTCGGCCACCAGCGAGACCCGGGCGACCGCCGGGGACATCGCGCAGGCGTGGGGCCTGAAGGACGTACGGGTCGGTGACCGGGCCGGGCACCTCGACGGTCCC	MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGP	MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGPPPRNFFAPPSLETVIRPERPEEAGRLHAALRMLDEQDPSIDLRQDEENAAGAVVRLYGEVQKEILGSTLAESFGVRVRFDPTRTVCIEKPVGTGEALIELDTRTHNYFWGAPWVCASDRPSPARAITFRLAVELGSLPLAFHKAIEETVHTTLRHGLYGWQVTDCAVTLTRTGVRSPVSAADDFRKANARLVLMDALGRAGTEVHEPVSSFELEVPAARLSPVLAKLAELGATPGVPTAEGDVFRLEGTMPTSLVHDFNQRVPGLTQGEGVFLAEHRGYRPAVGQPPVRPRPEGPNPLNRDEYILHVLKRV	53.09	gnl|BL_ORD_ID|4807|hsp_num:0	1273			0	1056	oxytetracycline
BGC0000254.1|Oxytetracycline_2 # 860 # 2047 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722	BGC0000254.1|Oxytetracycline_2 	860	2047	+	Loose	750	177.948	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	35.05	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGCTCACCGCGGGCCGTACCGCCACCCGCCCGATCTCGTCCTTCGACGCCTCGCCCTTCCGCTCCCAGGTGGCGGCGGAGTGCGACTTCGACCCGGCGGCGGAGGGGCTGAGCCAGCGGCAGGTCCGCGCCTGGGACCGCACCATGCAGTTCGCTTACGTGGCCGCGCGGGAGGCGCTGGCGGACAGCGGTGTGACGGGCGAGGCGGACCCGCTGCGCACCGGCGTCATGGCCGGCACCGCCTGCGGCATGACGATGAGCCTGGACCGCGAGTACGCGGTGGTCAGCGACGAGGGCCGGCTGTGGCAGGTGGACGACGCCCATGGGGTGCCGTACCTCTACGACTACTTCGTGCCCTCGTCGATGGCGGCCGAGATCGCCTGGCTGGCGGAGGCGGAGGGCCCGGCCGGGGTGGTCTCGGCCGGCTGCACCTCCGGCATCGACGTGCTCACCCACGCGGCGGACCTGGTACGCGACGGCGCGGCCGAGGTGATGGTGGCCGGGGCATCGGACGCCGCCATCTCCCCCATCACGGTGGCGTGCTTCGACGCGATCAAGGCCACCACGCCGCGCAACGACGAGCCGGAGACGGCGTCCCGTCCGTTCGACCGCACCCGCAACGGCTTCGTGCTGGGCGAGGGGGCGGCGTTCTTCGTCCTGGAGGAGTACGCGCACGCCAGGCGGCGGGGGGCCCGCGCGTACGCGGAGATCGCCGGGTACGCCGGGCGGTGCAACGCGTACAGCATGACCGGGCTGCGCTCGGACGGGCGGGAGCTGGCCGAGGCGGTGAGCCGCGCGCTCGACATCGCGCGCGTCGATCCGTCGGAGGTGGACTACGTCAACGCCCACGGTTCGGCGACCAAGCAGAACGATCTCCATGAGACGGCGGCGTTCAAGCGGAGCCTGGGTCCGCACGCCTACTCGGTCCCGATCAGCTCCATCAAATCGATGATCGGCCACTCGCTCGGTGCCATCTGCGCGCTGGAGGTCGCGGCGAGCGCGCTGAGGATCGAGCACGGGGTGATCCCACCCACCGCGAACCTGCGGGAGCCGGACCCCGACTGCGACCTGGACTATGTGCCGCTGGTCGCCAGGGAGGCCGAGGTGTCCACCGTGGTGTCCGTGGCCAGCGGATTCGGCGGCTTCCAGAGCGCGATCGTGCTCACCGAGCCGGGGAGGCAGCGATGA	MLTAGRTATRPISSFDASPFRSQVAAECDFDPAAEGLSQRQVRAWDRTMQFAYVAAREALADSGVTGEADPLRTGVMAGTACGMTMSLDREYAVVSDEGRLWQVDDAHGVPYLYDYFVPSSMAAEIAWLAEAEGPAGVVSAGCTSGIDVLTHAADLVRDGAAEVMVAGASDAAISPITVACFDAIKATTPRNDEPETASRPFDRTRNGFVLGEGAAFFVLEEYAHARRRGARAYAEIAGYAGRCNAYSMTGLRSDGRELAEAVSRALDIARVDPSEVDYVNAHGSATKQNDLHETAAFKRSLGPHAYSVPISSIKSMIGHSLGAICALEVAASALRIEHGVIPPTANLREPDPDCDLDYVPLVAREAEVSTVVSVASGFGGFQSAIVLTEPGRQR	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	94.95	gnl|BL_ORD_ID|1968|hsp_num:0	1943			279	1239	isoniazid
